$SGMT
Sagimet Biosciences Inc. Series A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$11.09
▼-0.72%-$0.080
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSagimet Biosciences Inc. Series A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SGMT down today? It is at $11.09 (-0.72%), and our scanner flagged it 48 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SGMT spikes, and full due diligence on SGMT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SGMT 48 times in the last 30 days. Create a free account to track $SGMT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SGMT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SGMT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kemble George Director | Sold (automatic/other) | -351K 1.1% of company | sold 85% | 62K | $3.6M at $10.23 | Aug 14, 26 |
Kemble George Director | Other | 351K 1.1% of company | added 100% | 413K | $2.2M at $6.36 | Aug 14, 26 |
Kemble George Director | Sold (automatic/other) | -20K 0.07% of company | sold 25% | 62K | $201K at $9.95 | Aug 11, 26 |
Kemble George Director | Other | 20K 0.07% of company | added 33% | 82K | $129K at $6.36 | Aug 11, 26 |
Kemble George Director | Sold (automatic/other) | -19K 0.06% of company | sold 23% | 62K | $141K at $7.46 | Jul 20, 26 |
Rozek Elizabeth Officer | Sold (automatic/other) | -11K 0.03% of company | sold 4.5% | 224K | $82K at $7.76 | Jul 20, 26 |
Happel David Officer | Sold (automatic/other) | -64K 0.2% of company | sold 8.0% | 742K | $497K at $7.76 | Jul 20, 26 |
Chauche Thierry Officer | Acquired (grant/award) | +44K 0.1% of company | added 100% | 60K | n/a | Feb 19, 26 |
Happel David Officer | Acquired (grant/award) | +128K 0.4% of company | added 19% | 806K | n/a | Feb 19, 26 |
Martins Eduardo Bruno Officer | Acquired (grant/award) | +44K 0.1% of company | added 43% | 147K | n/a | Feb 19, 26 |
Rozek Elizabeth Officer | Acquired (grant/award) | +44K 0.1% of company | added 23% | 235K | n/a | Feb 19, 26 |
Rozek Elizabeth Officer | Sold (automatic/other) | -3K | sold 1.4% | 191K | $14K at $5.36 | Feb 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SGMT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SGMT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SGMT last traded at $11.09, down 0.72% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SGMT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SGMT 48 times in the last 30 days.
SGMT (Sagimet Biosciences Inc. Series A Common Stock) trades on XNAS, with a market cap of about $340M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SGMT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SGMT discussion
Sign in to ask a question or join the discussion.